Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bright Green Corporation (BGXXQ) vs Universe Pharmaceuticals INC (UPC)

Bright Green Corporation and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. Universe Pharmaceuticals INC is the larger, with a market value of $23.5M against $13.9M — 1.7× the size. Bright Green Corporation has the higher net margin (0.00% vs −6.42%) and the lower return on invested capital (−39.4% vs 0.00%). Across the 10 metrics below, Universe Pharmaceuticals INC leads on 6 and Bright Green Corporation on 4.

Valuation

Metric BGXXQ UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m n/m 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 8.52 12.29
EV/Sales n/m (0.24) 2.56
Earnings yield 0.00% (30.74%) (2.99%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric BGXXQ UPC Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 49.77% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (6.42%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (73.60%) 0.00% (0.40%)
Return on assets (44.80%) 0.00% (3.32%)
Return on invested capital (39.35%) 0.00% 0.00%

Growth

Metric BGXXQ UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) 58.82% 98.71% —
Revenue growth, 5-year CAGR — (10.27%) 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BGXXQ UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.07 0.17 0.05
Current ratio 0.01 4.05 2.31
Net debt to EBITDA (0.02) 10.15 0.85

Dividend

Metric BGXXQ UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric BGXXQ UPC Drug Manufacturers Specialty & Generic median
Market cap 13.88m 23.54m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack